GUD.TO vs. SAP.TO
GUD.TO (Knight Therapeutics Inc.) and SAP.TO (Saputo Inc.) are both stocks. GUD.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare), while SAP.TO operates in Packaged Foods (Consumer Defensive). Over the past 10 years, GUD.TO returned 1.51%/yr vs 2.73%/yr for SAP.TO. At a 0.13 correlation, their price movements are largely independent.
Performance
GUD.TO vs. SAP.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GUD.TO achieves a 62.64% return, which is significantly higher than SAP.TO's 1.80% return. Over the past 10 years, GUD.TO has underperformed SAP.TO with an annualized return of 1.51%, while SAP.TO has yielded a comparatively higher 2.73% annualized return.
GUD.TO
- 1D
- 0.20%
- 1M
- 6.15%
- 6M
- 68.78%
- YTD
- 62.64%
- 1Y
- 62.64%
- 3Y*
- 26.34%
- 5Y*
- 13.91%
- 10Y*
- 1.51%
- ALL TIME*
- 7.54%
SAP.TO
- 1D
- -2.18%
- 1M
- 0.85%
- 6M
- 1.53%
- YTD
- 1.80%
- 1Y
- 49.23%
- 3Y*
- 16.65%
- 5Y*
- 5.33%
- 10Y*
- 2.73%
- ALL TIME*
- 11.37%
GUD.TO vs. SAP.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GUD.TO Knight Therapeutics Inc. | 62.64% | 13.30% | 2.89% | 0.19% | -2.26% | -0.93% | -29.42% | -1.43% | -7.46% | -22.63% |
SAP.TO Saputo Inc. | 1.80% | 69.59% | -4.35% | -18.00% | 20.36% | -18.33% | -9.55% | 4.28% | -11.88% | -3.55% |
Correlation
The correlation between GUD.TO and SAP.TO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Mar 3, 2014 | 0.13 |
Fundamentals
GUD.TO:
CA$966.08M
SAP.TO:
CA$16.68B
GUD.TO:
CA$0.06
SAP.TO:
CA$1.63
GUD.TO:
174.10
SAP.TO:
25.50
GUD.TO:
1.91
SAP.TO:
0.93
GUD.TO:
1.24
SAP.TO:
2.50
GUD.TO:
CA$510.45M
SAP.TO:
CA$18.41B
GUD.TO:
CA$190.52M
SAP.TO:
CA$2.23B
GUD.TO:
CA$65.18M
SAP.TO:
CA$1.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GUD.TO vs. SAP.TO — Risk / Return Rank
GUD.TO
SAP.TO
GUD.TO vs. SAP.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Knight Therapeutics Inc. (GUD.TO) and Saputo Inc. (SAP.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GUD.TO | SAP.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | +1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.39 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 5.21 | 3.08 | +2.13 |
| Martin ratioReturn relative to average drawdown | 10.04 | 9.81 | +0.23 |
Loading charts...
Drawdowns
GUD.TO vs. SAP.TO - Drawdown Comparison
The maximum GUD.TO drawdown since its inception was -60.09%, which is greater than SAP.TO's maximum drawdown of -44.63%. Use the drawdown chart below to compare losses from any high point for GUD.TO and SAP.TO.
Loading charts...
Drawdown Indicators
| GUD.TO | SAP.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.09% | -44.63% | -15.46% |
Max Drawdown (1Y)Largest decline over 1 year | -12.08% | -16.05% | +3.97% |
Max Drawdown (3Y)Largest decline over 3 years | -17.58% | -27.48% | +9.90% |
Max Drawdown (5Y)Largest decline over 5 years | -29.61% | -35.29% | +5.68% |
Max Drawdown (10Y)Largest decline over 10 years | -60.09% | -44.63% | -15.46% |
Current DrawdownCurrent decline from peak | -9.72% | -7.10% | -2.62% |
Average DrawdownAverage peak-to-trough decline | -34.25% | -13.75% | -20.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.26% | 5.03% | +1.23% |
Volatility
GUD.TO vs. SAP.TO - Volatility Comparison
The current volatility for Knight Therapeutics Inc. (GUD.TO) is 4.95%, while Saputo Inc. (SAP.TO) has a volatility of 7.94%. This indicates that GUD.TO experiences smaller price fluctuations and is considered to be less risky than SAP.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GUD.TO | SAP.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.95% | 7.94% | -2.99% |
Volatility (6M)Calculated over the trailing 6-month period | 20.55% | 18.61% | +1.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 24.01% | +0.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.21% | 23.20% | +1.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.13% | 22.69% | +1.44% |
Dividends
GUD.TO vs. SAP.TO - Dividend Comparison
GUD.TO has not paid dividends to shareholders, while SAP.TO's dividend yield for the trailing twelve months is around 1.92%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GUD.TO Knight Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SAP.TO Saputo Inc. | 1.92% | 1.89% | 3.00% | 2.72% | 2.15% | 2.49% | 1.94% | 1.67% | 1.66% | 1.37% | 1.20% | 1.60% |
Financials
GUD.TO vs. SAP.TO - Financials Comparison
This section allows you to compare key financial metrics between Knight Therapeutics Inc. and Saputo Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GUD.TO vs. SAP.TO - Profitability Comparison
GUD.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Knight Therapeutics Inc. reported a gross profit of 54.44M and revenue of 148.44M. Therefore, the gross margin over that period was 36.7%.
SAP.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Saputo Inc. reported a gross profit of 237.00M and revenue of 4.17B. Therefore, the gross margin over that period was 5.7%.
GUD.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Knight Therapeutics Inc. reported an operating income of 10.58M and revenue of 148.44M, resulting in an operating margin of 7.1%.
SAP.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Saputo Inc. reported an operating income of 237.00M and revenue of 4.17B, resulting in an operating margin of 5.7%.
GUD.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Knight Therapeutics Inc. reported a net income of 13.17M and revenue of 148.44M, resulting in a net margin of 8.9%.
SAP.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Saputo Inc. reported a net income of 102.00M and revenue of 4.17B, resulting in a net margin of 2.4%.
Frequently Asked Questions
GUD.TO and SAP.TO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GUD.TO and SAP.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer